Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT06919510
A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer
A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Lvonescimab and Chemotherapy Versus Neoadjuvant Short-course Radiotherapy Followed by Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer
Sponsor: Akeso
Conditions
Rectal Adenocarcinoma
Updated 1 time since 2025 Last updated: Apr 2, 2025 Started: Apr 1, 2025 Primary completion: Jun 1, 2026 Completion: Dec 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Rectal Adenocarcinoma, this trial is actively recruiting participants. The trial is conducted by Akeso and has accumulated 1 data snapshot since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Akeso
- Sun Yat-sen University
Data source: Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.